FDA Raps California Drugmaker Over SOPs

Drug Industry Daily
A A
The FDA cited FMK Labs for deficiencies in its standard operating procedures during an Oct. 16-22 inspection of its Corona, California facility.

To View This Article:

Login

Subscribe To Drug Industry Daily